Siemens Healthineers Opens New Ultrasound Manufacturing Facility in Košice, Slovakia

Siemens HealthineersSiemens Healthineers opened a new Ultrasound manufacturing facility in Košice, Slovakia, its first in Europe, with an initial capacity of up to 120 systems per week. The company will use this new facility to expand manufacturing capabilities for its ultrasound products, including the Acuson Sequoia and the Acuson Redwood. These products can have a significant impact on how clinicians treat and monitor their patients.

The facility in Košice will manufacture some portion of all general imaging and cardiovascular ultrasound systems and will supplement additional manufacturing facilities in Asia and the United States. The additional manufacturing facility will allow for a reduction of carbon emissions by more than 90 percent by ground shipping products to customers in Europe instead of via air freight from Asia.

"Being able to have products produced much closer to our customers in Europe, Middle East and Africa is hugely important, especially after all the shipping and supply chain challenges of the last couple of years. We need to be able to deliver what our customers need, when they need it, and this new facility allows us to do this in a much more agile way. We have had great success with our Research and Development facility in Košice and are excited to expand even more by adding manufacturing and other capabilities," says Ajay Gannerkote, president of the Ultrasound business area of Siemens Healthineers.

More than 30 new jobs have been created at the facility, while 300 more Siemens Healthineers employees are located in an office in downtown Košice. In Slovakia as a whole, over 800 employees are now working for Siemens Healthineers in offices in Bratislava, Žilina and Košice.

"The great advantage of Acuson Redwood is primarily its versatility, easy handling and mobility. It offers superior imaging capabilities for specialist departments as well as general radiology within a single hospital. From the patient's point of view, there is also a benefit in its quiet operation and in reducing the need for invasive procedures," says prof. MUDr. Gabriel Valočik, PhD, Head of the 1st Cardiology Clinic at the Faculty of Medicine UPJŠ and ESICD in Košice.

A ribbon-cutting ceremony was held at the facility, attended by Siemens Healthineers employees and executive leadership, along with local officials and management.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion.

Most Popular Now

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...